Spero Therapeutics, Inc. (SPRO)

1.23 +0.02 (+1.23%) USD  |  NASDAQ  |  Aug 25, 16:00
1.225 0.00 (0.00%) After-Hours: 19:59
More

Spero Therapeutics Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for SPRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2024. Start Trial.
Date Value
November 17, 2025 --
August 14, 2025 --
July 29, 2025 --
June 10, 2025 --
May 19, 2025 --
April 02, 2025 --
January 30, 2025 --
January 03, 2025 --
December 31, 2024 --
December 02, 2024 --
November 18, 2024 --
November 15, 2024 --
November 04, 2024 --
Date Value
August 06, 2024 --
August 05, 2024 --
May 16, 2024 --
May 15, 2024 --
April 04, 2024 --
March 18, 2024 --
March 14, 2024 --
March 13, 2024 --
March 04, 2024 --
February 23, 2024 --
January 06, 2024 --
January 03, 2024 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Inovio Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Kura Oncology, Inc. Upgrade
Legend Biotech Corp. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade